The US Food and Drug Administration (FDA) has approved avatrombopag (Doptelet, AkaRx Inc) to increase platelet counts in adults with thrombocytopenia and chronic liver disease who are to undergo a ...
The approval of Doptelet was based on results from the ADAPT-1 (N=231) and ADAPT-2 trials (N=204), 2 identically-designed multicenter, randomized, double-blind, placebo-controlled studies. The Food ...
WASHINGTON -- The FDA approved another thrombopoietin receptor agonist on Monday, for an indication not covered by other drugs intended to raise platelet counts. The new agent is avatrombopag ...
Patients undergoing transcatheter aortic valve replacement (TAVR) have decreases in platelet counts that are typically transient, lasting just a few days. But in those with preexisting ...
Doptelet (avatrombopag) is used to increase platelet count in certain situations. The typical dosage is 1 to 3 oral tablets taken once daily. Your specific dosage depends on factors such as your ...
A new study found that most routine laboratory tests are not reliable for diagnosing long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC). Anna Sjöström at the research group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results